At Samsung, the brains of TVs matter as much as their size
For the world's No. 1 TV seller, it's no longer all about bigger screens and thinner panels. Televisions have to be smart too.
Increased sensitivity for better detection
A group of European scientists from Imperial College London in the United Kingdom and the University of Vigo in Spain has made a technological breakthrough with its development of an ultra-sensitive test with the capacity ...
Scientists develop ultra-sensitive test that detects diseases in their earliest stages
Scientists have developed an ultra-sensitive test that should enable them to detect signs of a disease in its earliest stages, in research published today in the journal Nature Materials.
New file format will help 3-D printing progress
(PhysOrg.com) -- A newly approved standard for 3-D printing file interchange will greatly enhance 3-D printing capabilities, says Cornell's Hod Lipson, who led the development of the standard.
PSA test for men could get a second life for breast cancer in women
The widely known PSA blood test for prostate cancer in men may get a second life as a much-needed new test for breast cancer, the most common form of cancer in women worldwide, scientists are reporting in a new study in the ...
Rumor: Xbox 360 games to be playable on Windows 8 PC's
Talent show mulled for Timberlake's Myspace
(AP) -- Justin Timberlake's longtime manager Johnny Wright said Friday that a talent show or some other way of developing new artists will be core to the revamp of Myspace.
Allure of iPad, other tablets hurting PC sales
Last year, the popularity of Apple Inc.'s iPad hurt PC sales. This year, that trend is continuing, as new data from two market research firms indicate PC shipments declined in the first three months of 2011.
New drug targets vitamin D receptors in hormone resistant prostate cancers
A new anti-cancer drug aimed at vitamin D receptors on cancer cells has prompted encouraging responses in the levels of PSA (prostate specific antigen) in men with prostate cancer that has become resistant to hormonal therapies.
Prostate cancer screening improves quality of life by catching disease before it spreads
Men treated for prostate cancer who were diagnosed after the start of routine screening had a significantly reduced risk of the disease spreading to other parts of the body (metastases) within 10 years of treatment, compared ...
Biomarker panel identifies prostate cancer with 90 percent accuracy
Researchers in England say they have discovered a set of biomarkers that can distinguish prostate cancer from benign prostate disease and healthy tissue with 90 percent accuracy. This preliminary data, if validated in larger ...
Early prostate cancer detection, screening: No benefit for men with low baseline PSA value
Men aged 55 to 74 years who have low baseline blood levels of prostate specific antigen (PSA) are not likely to benefit from further screening and treatment. That is the conclusion of a new study published early online in ...
To screen or not to screen
Men with a family history of prostate cancer who are confused about whether to undergo controversial screening could soon have access to an online resource to have their questions answered.
Surprising find may yield new avenue of treatment for painful herniated discs
An immune cell known to cause chronic inflammation in autoimmune disorders has been identified as a possible culprit in low back pain associated with herniated discs, according to doctors at Duke University Medical Center.